MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells

被引:1
|
作者
Sui, Xiaoxin [1 ]
Xi, Xiaowei [2 ]
机构
[1] Naval Med Univ, Shanghai Changzheng Hosp, Dept Obstet & Gynecol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Shanghai Gen Hosp, Dept Obstet & Gynecol, Shanghai 201620, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
dendritic cells; cervical cancer; immunity; MCT1; LACTIC-ACID; T-CELLS; TUMOR;
D O I
10.17219/acem/171446
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background. Dendritic cells (DCs) are a key class of immune cells that migrate to the draining lymph nodes and present processed antigenic peptides to lymphocytes after being activated by external stimuli, thereby establishing adaptive immunity. Moreover, DCs play an important role in tumor immunity.Objectives. The aim of the study was to investigate whether MCT1 gene silencing in DCs affects their ability to mount an immune response against cervical cancer cells.Materials and methods. We silenced the expression of MCT1 in DCs from mouse bone marrow (BM) by infection with adenovirus. The surface antigen profile of DCs was analyzed by flow cytometry and cytokine secretion was evaluated using enzyme-linked immunosorbent assay (ELISA) following sodium lactate (sLA) exposure and lipopolysaccharide (LPS) stimulation. Then, various groups of DC-induced cytotoxic T lymphocytes (CTLs) were prepared and their cytotoxicity against U14 was tested.Results. Without sLA exposure, silencing MCT1 did not affect the expression of CD1a, CD80, CD83, CD86, and major histocompatibility complex class II (MHCII) in DCs after LPS challenge. Similar results were found for interleukin (IL)-6, IL-12 p70 and tumor necrosis factor alpha (TNF-alpha). After sLA exposure, silencing MCT1 significantly decreased the expression of CD1a, CD80, CD83, CD86, and MHCII in DCs after the LPS challenge, as well as the secretion of IL-6, IL-12 p70 and TNF-alpha. In addition, sLA exposure significantly reduced the toxicity and inhibited the proliferation of DC-induced CTLs compared to U14 cells in vitro and in vivo. However, silencing MCT1 significantly attenuated the changes caused by sLA exposure. At the same time, in the absence of sLA, silencing MCT1 did not affect the toxicity nor inhibit the proliferation of DC-induced CTLs on U14 cells. Conclusions. Lactate exposure reduces the immune effect of DCs on cervical cancer cells, but MCT1 gene silencing attenuates these alterations.
引用
收藏
页码:739 / 749
页数:11
相关论文
共 50 条
  • [41] Mechanisms underlying modulation of monocarboxylate transporter 1 (MCT1) by somatostatin in human intestinal epithelial cells
    Saksena, Seema
    Theegala, Saritha
    Bansal, Nikhil
    Gill, Ravinder K.
    Tyagi, Sangeeta
    Alrefai, Waddah A.
    Ramaswamy, Krishnamurthy
    Dudeja, Pradeep K.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009, 297 (05): : G878 - G885
  • [42] Dendritic cells and cytokines in immune rejection of cancer
    Ferrantini, Maria
    Capone, Imerio
    Belardelli, Filippo
    CYTOKINE & GROWTH FACTOR REVIEWS, 2008, 19 (01) : 93 - 107
  • [43] Quantification of MCT1 and CD147 in Red Blood Cells of Arabian and Quarter Horses
    Regatieri, Inae Cristina
    Mendes Almeida, Maria Luiza
    Teixeira Neto, Antonio Raphael
    Curi, Rogerio Abdallah
    Ferraz, Guilherme Camargo
    Queiroz-Neto, Antonio
    JOURNAL OF EQUINE VETERINARY SCIENCE, 2016, 43 : 66 - 71
  • [44] MCT1 lactate transporter blockade re-invigorates anti-tumor immunity through metabolic rewiring of dendritic cells in melanoma
    Niveau, Camille
    Cettour-Cave, Melanie
    Mouret, Stephane
    Sosa Cuevas, Eleonora
    Pezet, Mylene
    Roubinet, Benoit
    Gil, Hugo
    De Fraipont, Florence
    Landemarre, Ludovic
    Charles, Julie
    Saas, Philippe
    Aspord, Caroline
    NATURE COMMUNICATIONS, 2025, 16 (01)
  • [45] Curcumin derivative NL01 induces ferroptosis in ovarian cancer cells via HCAR1/MCT1 signaling
    Shi, Mengna
    Zhang, Min-Jie
    Yu, Yang
    Ou, Rongying
    Wang, Yiyan
    Li, Huitao
    Ge, Ren-shan
    CELLULAR SIGNALLING, 2023, 109
  • [46] CD147 regulates the expression of MCT1 and lactate export in multiple myeloma cells
    Walters, Denise K.
    Arendt, Bonnie K.
    Jelinek, Diane F.
    CELL CYCLE, 2013, 12 (19) : 3175 - 3183
  • [47] LORATADINE, A POTENT INHIBITOR OF LACTIC ACID TRANSPORTERS MCT1 AND MCT4 IN HUMAN SKELETAL MUSCLE CELLS.
    Leung, Y.
    Turgeon, J.
    Michaud, V.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S35 - S35
  • [48] CDNA CLONING OF MCT2, A 2ND MONOCARBOXYLATE TRANSPORTER EXPRESSED IN DIFFERENT CELLS THAN MCT1
    GARCIA, CK
    BROWN, MS
    PATHAK, RK
    GOLDSTEIN, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (04) : 1843 - 1849
  • [49] Effect of lipopolysaccharide on dendritic cells and anti-tumor immune response between dendritic cells fused with prostate cancer cells and tumor lysate-pulsed dendritic cells
    Doo, C. K.
    Yoo, C.
    Song, C.
    Min, G. E.
    Chung, H.
    Kim, C. S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 81 - 81
  • [50] Therapy-induced DNA methylation inactivates MCT1 and renders tumor cells vulnerable to MCT4 inhibition
    Vander Linden, Catherine
    Corbet, Cyril
    Bastien, Estelle
    Martherus, Ruben
    Guilbaud, Celine
    Petit, Laurenne
    Wauthier, Loris
    Loriot, Axelle
    De Smet, Charles
    Feron, Olivier
    CELL REPORTS, 2021, 35 (09):